As the Lead Analyst, I view the Sophorolipid Biosurfactant market as moderately attractive. The Sophorolipid Biosurfactant market outlook shows a 12‑14% CAGR to 2032, fueled by stringent sustainability regulations and rising consumer preference for natural surfactants in personal care, cosmetics, and food. Competitive intensity is moderate; a few established specialty chemical firms hold the bulk of production, while agile biotech start‑ups are entering via advanced fermentation platforms. High upstream feedstock costs and limited pilot‑scale capacity act as entry barriers, yet they also create partnership opportunities. The long‑term outlook remains positive, supported by expanding green‑label mandates and premium pricing power. Innovation landscape is vibrant, with strain‑engineering, waste‑derived carbon streams, and continuous‑process intensification aimed at reducing cost of goods. Currently, demand–supply balance is tilted toward demand, especially in Asia‑Pacific, but announced capacity expansions should ease tightness within five years. Key risk factors include feedstock price volatility, regulatory changes on GMO microorganisms, and the threat of lower‑cost alternative biosurfactants eroding market share.